Engineering short peptide sequences for uranyl binding.
暂无分享,去创建一个
[1] C. Gateau,et al. Design of intrahepatocyte copper(I) chelators as drug candidates for Wilson's disease , 2014, Annals of the New York Academy of Sciences.
[2] D. Testemale,et al. D-Penicillamine tripodal derivatives as efficient copper(I) chelators. , 2014, Inorganic chemistry.
[3] Luhua Lai,et al. A protein engineered to bind uranyl selectively and with femtomolar affinity. , 2014, Nature chemistry.
[4] C. Vidaud,et al. Characterization of UO2(2+) binding to osteopontin, a highly phosphorylated protein: insights into potential mechanisms of uranyl accumulation in bones. , 2014, Metallomics : integrated biometal science.
[5] G. Creff,et al. Osteopontin: a uranium phosphorylated binding-site characterization. , 2013, Chemistry.
[6] D. Testemale,et al. X-ray absorption spectroscopy proves the trigonal-planar sulfur-only coordination of copper(I) with high-affinity tripodal pseudopeptides. , 2013, Inorganic chemistry.
[7] G. Deblonde,et al. Solution thermodynamic evaluation of hydroxypyridinonate chelators 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO) for UO2(VI) and Th(IV) decorporation , 2013 .
[8] C. Lebrun,et al. Rational design of lanthanide binding peptides , 2013 .
[9] C. Vidaud,et al. Revision of the biodistribution of uranyl in serum: is fetuin-A the major protein target? , 2013, Chemical research in toxicology.
[10] A. Fragoso,et al. Copper(II) coordination properties of decapeptides containing three His residues: the impact of cyclization and Asp residue coordination. , 2013, Dalton transactions.
[11] A. Fragoso,et al. Harnessing the flexibility of peptidic scaffolds to control their copper(II)-coordination properties: a potentiometric and spectroscopic study. , 2013, Chemistry.
[12] Fangting Yu,et al. Designing a functional type 2 copper center that has nitrite reductase activity within α-helical coiled coils , 2012, Proceedings of the National Academy of Sciences.
[13] C. Soares,et al. Design of a peptidic turn with high affinity for Hg(II). , 2012, Inorganic chemistry.
[14] C. Berthomieu,et al. Modulating Uranium Binding Affinity in Engineered Calmodulin EF-Hand Peptides: Effect of Phosphorylation , 2012, PloS one.
[15] A. Manceau,et al. Mercury-Sequestering Pseudopeptides with a Tris(cysteine) Environment in Water , 2012 .
[16] D. Cassio,et al. A sulfur tripod glycoconjugate that releases a high-affinity copper chelator in hepatocytes. , 2012, Angewandte Chemie.
[17] C. Lebrun,et al. Femtomolar Ln(III) affinity in peptide-based ligands containing unnatural chelating amino acids. , 2012, Inorganic chemistry.
[18] C. Lebrun,et al. Lanthanide-binding peptides with two pendant aminodiacetate arms: impact of the sequence on chelation. , 2012, Dalton transactions.
[19] L. Hemmingsen,et al. Towards the role of metal ions in the structural variability of proteins: CdII speciation of a metal ion binding loop motif. , 2011, Metallomics : integrated biometal science.
[20] C. Lebrun,et al. A series of tripodal cysteine derivatives as water-soluble chelators that are highly selective for copper(I). , 2011, Chemistry.
[21] D. Boturyn,et al. Access to biomolecular assemblies through one-pot triple orthogonal chemoselective ligations. , 2011, Angewandte Chemie.
[22] O. Renaudet,et al. Hepatocyte targeting and intracellular copper chelation by a thiol-containing glycocyclopeptide. , 2011, Journal of the American Chemical Society.
[23] C. Vidaud,et al. Surface plasmon resonance for rapid screening of uranyl affine proteins. , 2010, Analytical chemistry.
[24] J. Pellequer,et al. Predicting the disruption by UO22+ of a protein‐ligand interaction , 2010, Protein science : a publication of the Protein Society.
[25] Deborah I. Bunin,et al. Biomimetic actinide chelators: an update on the preclinical development of the orally active hydroxypyridonate decorporation agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO). , 2010, Health physics.
[26] P. Fries,et al. Outer-sphere investigation of MRI relaxation contrast agents. Example of a cyclodecapeptide gadolinium complex with second-sphere water. , 2010, The journal of physical chemistry. B.
[27] P. Labbé,et al. Template-assembled synthetic G-quadruplex (TASQ): a useful system for investigating the interactions of ligands with constrained quadruplex topologies. , 2010, Chemistry.
[28] C. Lebrun,et al. A lanthanide binding peptide with short chelating side-chains: structural impact of the backbone coordination. , 2010, Dalton transactions.
[29] C. Garnier,et al. Determinations of Uranium(VI) Binding Properties with some Metalloproteins (Transferrin, Albumin, Metallothionein and Ferritin) by Fluorescence Quenching , 2010, Journal of Fluorescence.
[30] C. Apostolidis,et al. Spectroscopic study of the interaction of U(VI) with transferrin and albumin for speciation of U(VI) under blood serum conditions. , 2009, Journal of inorganic biochemistry.
[31] C. Lebrun,et al. Lanthanide(III) complexes with two hexapeptides incorporating unnatural chelating amino acids: secondary structure and stability. , 2009, Chemistry.
[32] D. Boturyn,et al. A gadolinium-binding cyclodecapeptide with a large high-field relaxivity involving second-sphere water. , 2009, Chemistry.
[33] C. Vidaud,et al. Identification of uranyl binding proteins from human kidney-2 cell extracts by immobilized uranyl affinity chromatography and mass spectrometry. , 2009, Journal of chromatography. A.
[34] V. Pecoraro,et al. Understanding the biological chemistry of mercury using a de novo protein design strategy , 2009 .
[35] C. Lebrun,et al. A cysteine-based tripodal chelator with a high affinity and selectivity for copper(I). , 2009, Journal of the American Chemical Society.
[36] Chuan He,et al. Engineering a uranyl-specific binding protein from NikR. , 2009, Angewandte Chemie.
[37] C. Vidaud,et al. Specific capture of uranyl protein targets by metal affinity chromatography. , 2008, Journal of chromatography. A.
[38] C. Vidaud,et al. High-affinity uranyl-specific antibodies suitable for cellular imaging. , 2008, Chemical research in toxicology.
[39] P. Durbin. Actinides in Animals and Man , 2008 .
[40] C. Auwer,et al. Review of actinide decorporation with chelating agents , 2007 .
[41] L. Rao,et al. Complexation of UVI with 1-hydroxyethane-1,1-diphosphonic acid in acidic to basic solutions. , 2007, Inorganic chemistry.
[42] C. Vidaud,et al. Structural consequences of binding of UO2(2+) to apotransferrin: can this protein account for entry of uranium into human cells? , 2007, Biochemistry.
[43] J. Pellequer,et al. Structural insights into protein-uranyl interaction: towards an in silico detection method. , 2006, Biochimie.
[44] M. Carrière,et al. Actinide speciation in relation to biological processes. , 2006, Biochimie.
[45] M. Ferrand,et al. Model peptides based on the binding loop of the copper metallochaperone Atx1: selectivity of the consensus sequence MxCxxC for metal ions Hg(II), Cu(I), Cd(II), Pb(II), and Zn(II). , 2006, Inorganic chemistry.
[46] P. Dumy,et al. Control of amyloid beta-peptide protofibril formation by a designed template assembly. , 2006, Angewandte Chemie.
[47] Huan Huang,et al. Uranium(VI) bio-coordination chemistry from biochemical, solution and protein structural data , 2006 .
[48] C. Vita,et al. Selective binding of uranyl cation by a novel calmodulin peptide , 2006 .
[49] S. Chierici,et al. Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines. , 2005, Bioconjugate chemistry.
[50] F. Taran,et al. Discovery of powerful uranyl ligands from efficient synthesis and screening. , 2005, Chemistry.
[51] C. Vidaud,et al. Screening of human serum proteins for uranium binding. , 2005, Chemical research in toxicology.
[52] J. V. Van Horn,et al. Uranyl-peptide interactions in carbonate solution with DAHK and derivatives. , 2005, Inorganic chemistry.
[53] J. Covès,et al. Is the cytoplasmic loop of MerT, the mercuric ion transport protein, involved in mercury transfer to the mercuric reductase? , 2004, FEBS letters.
[54] Jean-Luc Coll,et al. Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis. , 2004, Journal of the American Chemical Society.
[55] M. Ferrand,et al. Novel model peptide for Atx1-like metallochaperones. , 2004, Chemical communications.
[56] Robert M. Smith,et al. NIST standard reference database 46 version 8.0: NIST critically selected stability constants of metal complexes , 2004 .
[57] Robert M. Smith,et al. NIST Critically Selected Stability Constants of Metal Complexes Database , 2004 .
[58] Jide Xu,et al. Rational design of sequestering agents for plutonium and other actinides. , 2003, Chemical reviews.
[59] J. Renshaw,et al. Synthesis and characterization of uranyl compounds with iminodiacetate and oxydiacetate displaying variable denticity. , 2002, Inorganic chemistry.
[60] M. Crisma,et al. Crystal Structure of a Synthetic Cyclodecapeptide for Template‐Assembled Synthetic Protein Design , 2001, Chembiochem : a European journal of chemical biology.
[61] C. Madic,et al. Uranium (VI)-Transferrin System Studied by Time-Resolved Laser-Induced Fluorescence , 1998 .
[62] D. Taylor,et al. Environmental Uranium and Human Health , 1997, Reviews on environmental health.
[63] M. Mutter,et al. Solution structure of regioselectively addressable functionalized templates: an NMR and restrained molecular dynamics investigation. , 1998, Biopolymers.
[64] B. Imperiali,et al. A conformational study of peptides with the general structure Ac-L-Xaa-Pro-D-Xaa-L-Xaa-NH2: spectroscopic evidence for a peptide with significant .beta.-turn character in water and in dimethyl sulfoxide , 1992 .
[65] K. Kopple,et al. Reverse Turns in Peptides and Protein , 1980 .
[66] G. Choppin,et al. The complexation of lanthanides by aminocarboxylate ligands—I: Stability constants , 1977 .